{"id":"https://openalex.org/W3092563979","doi":"https://doi.org/10.1021/acs.jmedchem.0c00978","title":"Discovery of CC-90011: A Potent and Selective Reversible Inhibitor of Lysine Specific Demethylase 1 (LSD1)","display_name":"Discovery of CC-90011: A Potent and Selective Reversible Inhibitor of Lysine Specific Demethylase 1 (LSD1)","publication_year":2020,"publication_date":"2020-10-09","ids":{"openalex":"https://openalex.org/W3092563979","doi":"https://doi.org/10.1021/acs.jmedchem.0c00978","mag":"3092563979","pmid":"https://pubmed.ncbi.nlm.nih.gov/33034194"},"language":"en","primary_location":{"id":"doi:10.1021/acs.jmedchem.0c00978","doi":"https://doi.org/10.1021/acs.jmedchem.0c00978","is_oa":true,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.0c00978","pdf_url":"https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c00978","source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c00978","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006753753","display_name":"Toufike Kanouni","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toufike Kanouni","raw_affiliation_strings":["Fount Therapeutics, LLC , , ,","Fount Therapeutics, LLC, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fount Therapeutics, LLC , , ,","institution_ids":[]},{"raw_affiliation_string":"Fount Therapeutics, LLC, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023626325","display_name":"Christophe Severin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]},{"id":"https://openalex.org/I4210125795","display_name":"Bristol-Myers Squibb (United Kingdom)","ror":"https://ror.org/03emf1n04","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4210125795"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Christophe Severin","raw_affiliation_strings":["Bristol Myers Squibb , 10300 Campus Point Drive, Suite 100 , , ,","Bristol Myers Squibb, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb , 10300 Campus Point Drive, Suite 100 , , ,","institution_ids":["https://openalex.org/I4210091812","https://openalex.org/I4210125795"]},{"raw_affiliation_string":"Bristol Myers Squibb, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064741571","display_name":"Robert W. Cho","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert W. Cho","raw_affiliation_strings":["Quanticel Pharmaceuticels , , ,","Quanticel Pharmaceuticels, San Francisco, California 94158, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quanticel Pharmaceuticels , , ,","institution_ids":[]},{"raw_affiliation_string":"Quanticel Pharmaceuticels, San Francisco, California 94158, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034391681","display_name":"Natalie Yuen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405264651","display_name":"ORIC Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/02hx4p162","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Natalie Y.-Y. Yuen","raw_affiliation_strings":["Oric Pharmaceuticals , , ,","Oric Pharmaceuticals, South San Francisco, California 94080, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oric Pharmaceuticals , , ,","institution_ids":["https://openalex.org/I4405264651"]},{"raw_affiliation_string":"Oric Pharmaceuticals, South San Francisco, California 94080, United States","institution_ids":["https://openalex.org/I4405264651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057999868","display_name":"Jiangchun Xu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]},{"id":"https://openalex.org/I4210125795","display_name":"Bristol-Myers Squibb (United Kingdom)","ror":"https://ror.org/03emf1n04","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4210125795"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Jiangchun Xu","raw_affiliation_strings":["Bristol Myers Squibb , 10300 Campus Point Drive, Suite 100 , , ,","Bristol Myers Squibb, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb , 10300 Campus Point Drive, Suite 100 , , ,","institution_ids":["https://openalex.org/I4210091812","https://openalex.org/I4210125795"]},{"raw_affiliation_string":"Bristol Myers Squibb, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017281481","display_name":"Lihong Shi","orcid":"https://orcid.org/0009-0006-9229-1483","observed_orcids":["https://orcid.org/0009-0006-9229-1483"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]},{"id":"https://openalex.org/I4210125795","display_name":"Bristol-Myers Squibb (United Kingdom)","ror":"https://ror.org/03emf1n04","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4210125795"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Lihong Shi","raw_affiliation_strings":["Bristol Myers Squibb , 10300 Campus Point Drive, Suite 100 , , ,","Bristol Myers Squibb, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb , 10300 Campus Point Drive, Suite 100 , , ,","institution_ids":["https://openalex.org/I4210091812","https://openalex.org/I4210125795"]},{"raw_affiliation_string":"Bristol Myers Squibb, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035919170","display_name":"Chon Lai","orcid":"https://orcid.org/0009-0006-0253-8826","observed_orcids":["https://orcid.org/0009-0006-0253-8826"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]},{"id":"https://openalex.org/I4210125795","display_name":"Bristol-Myers Squibb (United Kingdom)","ror":"https://ror.org/03emf1n04","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4210125795"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Chon Lai","raw_affiliation_strings":["Bristol Myers Squibb , 10300 Campus Point Drive, Suite 100 , , ,","Bristol Myers Squibb, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb , 10300 Campus Point Drive, Suite 100 , , ,","institution_ids":["https://openalex.org/I4210091812","https://openalex.org/I4210125795"]},{"raw_affiliation_string":"Bristol Myers Squibb, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050181532","display_name":"Joselyn R. Del Rosario","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]},{"id":"https://openalex.org/I4210125795","display_name":"Bristol-Myers Squibb (United Kingdom)","ror":"https://ror.org/03emf1n04","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4210125795"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Joselyn R. Del Rosario","raw_affiliation_strings":["Bristol Myers Squibb , 10300 Campus Point Drive, Suite 100 , , ,","Bristol Myers Squibb, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb , 10300 Campus Point Drive, Suite 100 , , ,","institution_ids":["https://openalex.org/I4210091812","https://openalex.org/I4210125795"]},{"raw_affiliation_string":"Bristol Myers Squibb, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006718653","display_name":"Ryan K. Stansfield","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ryan K. Stansfield","raw_affiliation_strings":["858 Therapeutics, Inc. , , ,","858 Therapeutics, Inc., San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"858 Therapeutics, Inc. , , ,","institution_ids":[]},{"raw_affiliation_string":"858 Therapeutics, Inc., San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029765553","display_name":"Lee N. Lawton","orcid":"https://orcid.org/0000-0001-7824-9787","observed_orcids":["https://orcid.org/0000-0001-7824-9787"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lee N. Lawton","raw_affiliation_strings":["Dana-Farber Cancer Institute , , ,","Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute , , ,","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059300612","display_name":"David J. Hosfield","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Hosfield","raw_affiliation_strings":["University of Chicago , , ,","University of Chicago, Chicago, Illinois 60637, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago , , ,","institution_ids":["https://openalex.org/I40347166"]},{"raw_affiliation_string":"University of Chicago, Chicago, Illinois 60637, United States","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114046056","display_name":"Shawn M. O\u2019Connell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shawn O\u2019Connell","raw_affiliation_strings":["Pfizer Inc. , , ,","Pfizer Inc., San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc. , , ,","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Pfizer Inc., San Diego, California 92121, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059022935","display_name":"Matthew M. Kreilein","orcid":"https://orcid.org/0000-0002-9194-8336","observed_orcids":["https://orcid.org/0000-0002-9194-8336"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matt M. Kreilein","raw_affiliation_strings":["Bristol Myers Squibb , , ,","Bristol Myers Squibb, Summit, New Jersey 07901, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb , , ,","institution_ids":["https://openalex.org/I4210091812"]},{"raw_affiliation_string":"Bristol Myers Squibb, Summit, New Jersey 07901, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005003686","display_name":"Paula A. Tavares-Greco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paula Tavares-Greco","raw_affiliation_strings":["Bristol Myers Squibb , , ,","Bristol Myers Squibb, Summit, New Jersey 07901, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb , , ,","institution_ids":["https://openalex.org/I4210091812"]},{"raw_affiliation_string":"Bristol Myers Squibb, Summit, New Jersey 07901, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079354153","display_name":"Zhe Nie","orcid":"https://orcid.org/0009-0009-5125-8929","observed_orcids":["https://orcid.org/0009-0009-5125-8929"]},"institutions":[{"id":"https://openalex.org/I203455613","display_name":"Schrodinger (United States)","ror":"https://ror.org/05a3z6914","country_code":"US","type":"company","lineage":["https://openalex.org/I203455613"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhe Nie","raw_affiliation_strings":["Schro\u0308dinger, Inc. , , ,","Schr\u00f6dinger, Inc., San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Schro\u0308dinger, Inc. , , ,","institution_ids":["https://openalex.org/I203455613"]},{"raw_affiliation_string":"Schr\u00f6dinger, Inc., San Diego, California 92121, United States","institution_ids":["https://openalex.org/I203455613"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002790669","display_name":"Stephen W. Kaldor","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen W. Kaldor","raw_affiliation_strings":["Fount Therapeutics, LLC , , ,","Fount Therapeutics, LLC, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fount Therapeutics, LLC , , ,","institution_ids":[]},{"raw_affiliation_string":"Fount Therapeutics, LLC, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032507203","display_name":"James M. Veal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James M. Veal","raw_affiliation_strings":["858 Therapeutics, Inc. , , ,","858 Therapeutics, Inc., San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"858 Therapeutics, Inc. , , ,","institution_ids":[]},{"raw_affiliation_string":"858 Therapeutics, Inc., San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017412522","display_name":"Jeffrey A. Stafford","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey A. Stafford","raw_affiliation_strings":["858 Therapeutics, Inc. , , ,","858 Therapeutics, Inc., San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"858 Therapeutics, Inc. , , ,","institution_ids":[]},{"raw_affiliation_string":"858 Therapeutics, Inc., San Diego, California 92121, United States","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064672555","display_name":"Young K. Chen","orcid":"https://orcid.org/0000-0001-9354-0302","observed_orcids":["https://orcid.org/0000-0001-9354-0302"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]},{"id":"https://openalex.org/I4210125795","display_name":"Bristol-Myers Squibb (United Kingdom)","ror":"https://ror.org/03emf1n04","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4210125795"]}],"countries":["GB","US"],"is_corresponding":true,"raw_author_name":"Young K. Chen","raw_affiliation_strings":["Bristol Myers Squibb , 10300 Campus Point Drive, Suite 100 , , ,","Bristol Myers Squibb, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States"],"raw_orcid":"https://orcid.org/0000-0001-9354-0302","affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb , 10300 Campus Point Drive, Suite 100 , , ,","institution_ids":["https://openalex.org/I4210091812","https://openalex.org/I4210125795"]},{"raw_affiliation_string":"Bristol Myers Squibb, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States","institution_ids":["https://openalex.org/I4210091812"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5064672555"],"corresponding_institution_ids":["https://openalex.org/I4210091812","https://openalex.org/I4210125795"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":{"value":5000,"currency":"USD","value_usd":5000},"fwci":5.2068,"has_fulltext":false,"cited_by_count":142,"citation_normalized_percentile":{"value":0.97358083,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"63","issue":"23","first_page":"14522","last_page":"14529"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13157","display_name":"Cancer-related gene regulation","score":0.30979999899864197,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13157","display_name":"Cancer-related gene regulation","score":0.30979999899864197,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.23839999735355377,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.15440000593662262,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lsd1","display_name":"LSD1","score":0.8799999952316284},{"id":"https://openalex.org/keywords/reversible-inhibitors","display_name":"reversible inhibitors","score":0.6710000038146973},{"id":"https://openalex.org/keywords/histone-demethylase-inhibitors","display_name":"histone demethylase inhibitors","score":0.8619999885559082},{"id":"https://openalex.org/keywords/small-cell-lung-cancer","display_name":"small cell lung cancer","score":0.828000009059906},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8159999847412109},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.7419999837875366},{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"cancer therapy","score":0.48500001430511475},{"id":"https://openalex.org/keywords/tranylcypromine","display_name":"tranylcypromine","score":0.8330000042915344}],"concepts":[{"id":"https://openalex.org/C2781364455","wikidata":"https://www.wikidata.org/wiki/Q2531584","display_name":"Demethylase","level":4,"score":0.814024806022644},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.687664806842804},{"id":"https://openalex.org/C2777118369","wikidata":"https://www.wikidata.org/wiki/Q420885","display_name":"Tranylcypromine","level":4,"score":0.6663684844970703},{"id":"https://openalex.org/C69366308","wikidata":"https://www.wikidata.org/wiki/Q2272286","display_name":"ADME","level":3,"score":0.542632520198822},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5055665969848633},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.4789983928203583},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4619918167591095},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.44369128346443176},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.42354628443717957},{"id":"https://openalex.org/C2778396349","wikidata":"https://www.wikidata.org/wiki/Q410994","display_name":"Farnesyltransferase","level":4,"score":0.41208046674728394},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.329550176858902},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.26761770248413086},{"id":"https://openalex.org/C2776024655","wikidata":"https://www.wikidata.org/wiki/Q410867","display_name":"Monoamine oxidase","level":3,"score":0.26136869192123413},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.22544461488723755},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17956328392028809},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1333252489566803},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.12160941958427429},{"id":"https://openalex.org/C57790582","wikidata":"https://www.wikidata.org/wiki/Q901141","display_name":"Prenylation","level":3,"score":0.10687625408172607}],"mesh":[{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009930","descriptor_name":"Organic Chemicals","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009930","descriptor_name":"Organic Chemicals","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056466","descriptor_name":"Histone Demethylases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1021/acs.jmedchem.0c00978","doi":"https://doi.org/10.1021/acs.jmedchem.0c00978","is_oa":true,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.0c00978","pdf_url":"https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c00978","source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:33034194","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33034194","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1021/acs.jmedchem.0c00978","doi":"https://doi.org/10.1021/acs.jmedchem.0c00978","is_oa":true,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.0c00978","pdf_url":"https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c00978","source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W3092563979.pdf"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W1603797292","https://openalex.org/W2002155237","https://openalex.org/W2004499293","https://openalex.org/W2004990739","https://openalex.org/W2077872976","https://openalex.org/W2098356010","https://openalex.org/W2142303705","https://openalex.org/W2148383862","https://openalex.org/W2160384674","https://openalex.org/W2163924896","https://openalex.org/W2259755988","https://openalex.org/W2499896871","https://openalex.org/W2520159331","https://openalex.org/W2559321714","https://openalex.org/W2726225234","https://openalex.org/W2785262117","https://openalex.org/W2794180511","https://openalex.org/W2883462188","https://openalex.org/W2891223523","https://openalex.org/W2898359511","https://openalex.org/W2935013408","https://openalex.org/W2976008201","https://openalex.org/W4211173018","https://openalex.org/W4212766227"],"related_works":["https://openalex.org/W3130922855","https://openalex.org/W3087037618","https://openalex.org/W2993378407","https://openalex.org/W4235507425","https://openalex.org/W4403979279","https://openalex.org/W7133528574","https://openalex.org/W4321763627","https://openalex.org/W4214493968","https://openalex.org/W3209489681","https://openalex.org/W2954270534"],"abstract_inverted_index":{"Histone":[0],"demethylase":[1],"LSDl":[2,66,87],"(KDMlA)":[3],"belongs":[4],"to":[5,53],"the":[6,77,101],"flavin":[7],"adenine":[8],"dinucleotide":[9],"(FAD)":[10],"dependent":[11],"family":[12],"of":[13,21,27,31,34,49,65,79,83,90,96,103,112],"monoamine":[14],"oxidases":[15],"and":[16,25,85,94,120,128],"is":[17,138],"vital":[18],"in":[19,100,115,131,140,144],"regulation":[20],"mammalian":[22],"biology.":[23],"Dysregulation":[24],"overexpression":[26],"LSD1":[28,50],"are":[29,40,67],"hallmarks":[30],"a":[32,57,80],"number":[33],"human":[35],"diseases,":[36],"particularly":[37],"cancers":[38],"that":[39],"characterized":[41],"as":[42,56],"morphologically":[43],"poorly":[44],"differentiated.":[45],"As":[46],"such,":[47],"inhibitors":[48,64,69],"have":[51],"potential":[52],"be":[54],"beneficial":[55],"cancer":[58,124],"therapy.":[59],"The":[60],"most":[61],"clinically":[62],"advanced":[63],"covalent":[68],"derived":[70],"from":[71],"tranylcypromine":[72],"(TCP).":[73],"Herein,":[74],"we":[75],"report":[76],"discovery":[78],"novel":[81],"series":[82],"reversible":[84],"selective":[86],"inhibitors.":[88],"Exploration":[89],"structure-activity":[91],"relationships":[92],"(SARs)":[93],"optimization":[95],"ADME":[97],"properties":[98],"resulted":[99],"identification":[102],"clinical":[104],"candidate":[105],"CC-90011.":[106],"CC-90011":[107,137],"exhibits":[108],"potent":[109],"on-target":[110],"induction":[111],"cellular":[113],"differentiation":[114],"acute":[116],"myeloid":[117],"leukemia":[118],"(AML)":[119],"small":[121],"cell":[122,126],"lung":[123],"(SCLC)":[125],"lines,":[127],"antitumor":[129],"efficacy":[130],"patient-derived":[132],"xenograft":[133],"(PDX)":[134],"SCLC":[135,151],"models.":[136],"currently":[139],"phase":[141],"2":[142],"trials":[143],"patients":[145],"with":[146],"first":[147],"line,":[148],"extensive":[149],"stage":[150],"(ClinicalTrials.gov":[152],"identifier:":[153],"NCT03850067).":[154]},"counts_by_year":[{"year":2026,"cited_by_count":20},{"year":2025,"cited_by_count":30},{"year":2024,"cited_by_count":32},{"year":2023,"cited_by_count":25},{"year":2022,"cited_by_count":22},{"year":2021,"cited_by_count":13}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-10-15T00:00:00"}